Significant progress with late pre-clinical development of lead ReN001 stroke therapy, including repeat efficacy and dose response data and completion of scale-up to full cGMP1 standard
Significant progress with late pre-clinical development of lead ReN001 stroke therapy, including repeat efficacy and dose response data and completion of scale-up to full cGMP1 standard
